Cancer Therapy News and Research

RSS

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Eli Lilly and Company announced results today from two preclinical studies of molecules that target genetic mutations and disable specific signaling pathways that can lead to cancer. The studies evaluated two unique molecules – a JAK2 inhibitor and a Hedgehog inhibitor – with results presented during the American Association for Cancer Research (AACR) 102nd Annual Meeting in Orlando, Fla.

5 Apr 2011

New anti-angiogenic therapy can lead to tumour growth inhibition

Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd, announce the first publication describing a potential new anti-angiogenic therapy based on a natural protein first discovered at QUB. Anti-angiogenics prevent the growth of new blood vessels in tumours and starve them of nutrients, leading to inhibition of tumour growth.

4 Apr 2011

Men who consume digoxin have 24% reduced risk of prostate cancer

Johns Hopkins scientists and their colleagues paired laboratory and epidemiologic data to find that men using the cardiac drug, digoxin, had a 24 percent lower risk for prostate cancer. The scientists say further research about the discovery may lead to use of the drug, or new ones that work the same way, to treat the cancer.

4 Apr 2011

Scientists identify new treatment target for squamous cell lung cancer

Scientists at the Dana Farber Cancer Institute have identified a mutation in the DDR2 gene that may indicate which patients with squamous cell lung cancer will respond to dasatinib.

4 Apr 2011

Scientists identify digoxin as possible therapy for prostate cancer

Scientists have identified digoxin as a possible therapy for prostate cancer, using a combination of laboratory science and epidemiology that is unprecedented in its cooperative nature.

4 Apr 2011

New research identifies diverse barriers to breast cancer screening and treatment

A landmark breast health care publication reveals a multitude of barriers that keep women of developing nations from being screened and treated for breast cancer - but offers tools to help countries improve their breast care programs.

2 Apr 2011

Oncologist issues 'Emergency Radiation Medical Handbook'

Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.

2 Apr 2011

Oncology experts educate lawmakers about latest information on radiation therapy

Leaders from the radiation oncology community – representing patients, physicians, providers, and manufacturers – met on Capitol Hill today to educate lawmakers and their staffs about the latest in radiation therapy technologies and techniques, improvements in patient care and the community's focus on patient safety in radiation therapy delivery.

1 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.

1 Apr 2011

DNA damage can lead to regulation of inflammatory responses

Researchers offer the first evidence that DNA damage can lead to the regulation of inflammatory responses, the body's reaction to injury. The proteins involved in the regulation help protect the body from infection.

1 Apr 2011

Medicare moves to pay for Provenge

On Wednesday, Medicare officials signaled the federal insurance program will pay for this costly prostate cancer drug, a move that National Journal described as heading off "accusations that the [government] would be 'rationing' care."

1 Apr 2011

NCI awards Case Western Reserve with $1.6 million grant for cancer research

Case Western Reserve University School of Medicine has received a $1.6 million grant from the National Cancer Institute to study how tumor cells avoid detection by the body's immune system, allowing cancer to develop and spread.

1 Apr 2011

Cancer Commons researchers publish MDMM paper in PLoS ONE journal

Cancer Commons, an initiative of CollabRx, a provider of information technology to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model of melanoma which classifies the disease into molecular subtypes, rather than traditional histological or cellular subtypes, and describes treatment guidelines for each subtype, including specific assays, drugs, and clinical trials.

31 Mar 2011

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

CEL-SCI Corporation announced today that the State of Israel's Ministry of Health has given approval to begin enrollment of subjects for a Phase III clinical trial of Multikine in Israel.

31 Mar 2011

CCAC National Survey finds 82% of Canadians with cancer

The Colorectal Cancer Association of Canada today announced findings from the Weighing Quality of Life in Cancer National Survey showing that an alarming 82 per cent of Canadians have been touched closely by cancer and have had a close friend or family member battle cancer, or have done so themselves.

31 Mar 2011

Cancer Therapy News and Research

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

New anti-angiogenic therapy can lead to tumour growth inhibition

Men who consume digoxin have 24% reduced risk of prostate cancer

Scientists identify new treatment target for squamous cell lung cancer

Scientists identify digoxin as possible therapy for prostate cancer

New research identifies diverse barriers to breast cancer screening and treatment

Oncologist issues 'Emergency Radiation Medical Handbook'

Oncology experts educate lawmakers about latest information on radiation therapy

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

DNA damage can lead to regulation of inflammatory responses

Medicare moves to pay for Provenge

NCI awards Case Western Reserve with $1.6 million grant for cancer research

Cancer Commons researchers publish MDMM paper in PLoS ONE journal

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

CCAC National Survey finds 82% of Canadians with cancer

Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy

Researchers develop new drug for multiple cancer treatment

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Scientists to discover new estrogen receptor-signaling networks for breast cancer treatment

New study: Many elderly men may overuse PSA testing

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News